A novel role for pro-coagulant microvesicles in the early host defense against streptococcus pyogenes.
Previous studies have shown that stimulation of whole blood or peripheral blood mononuclear cells with bacterial virulence factors results in the sequestration of pro-coagulant microvesicles (MVs). These particles explore their clotting activity via the extrinsic and intrinsic pathway of coagulation; however, their pathophysiological role in infectious diseases remains enigmatic. Here we describe that the interaction of pro-coagulant MVs with bacteria of the species Streptococcus pyogenes is part of the early immune response to the invading pathogen. As shown by negative staining electron microscopy and clotting assays, pro-coagulant MVs bind in the presence of plasma to the bacterial surface. Fibrinogen was identified as a linker that, through binding to the M1 protein of S. pyogenes, allows the opsonization of the bacteria by MVs. Surface plasmon resonance analysis revealed a strong interaction between pro-coagulant MVs and fibrinogen with a KD value in the nanomolar range. When performing a mass-spectrometry-based strategy to determine the protein quantity, a significant up-regulation of the fibrinogen-binding integrins CD18 and CD11b on pro-coagulant MVs was recorded. Finally we show that plasma clots induced by pro-coagulant MVs are able to prevent bacterial dissemination and possess antimicrobial activity. These findings were confirmed by in vivo experiments, as local treatment with pro-coagulant MVs dampens bacterial spreading to other organs and improved survival in an invasive streptococcal mouse model of infection. Taken together, our data implicate that pro-coagulant MVs play an important role in the early response of the innate immune system in infectious diseases.
University Medicine, Institute of Medical Microbiology, Virology and Hygiene, Rostock University, Rostock, Germany. sonja.oehmeck@med.uni-rostock.de
Sonja
S
Oehmcke
Johannes
J
Westman
Johan
J
Malmström
Matthias
M
Mörgelin
Anders I
AI
Olin
Bernd
B
Kreikemeyer
Heiko
H
Herwald
D000818:Animals; D001777:Blood Coagulation / Q000276:immunology*; D039481:CD11b Antigen / Q000276:immunology* / Q000378:metabolism; D018821:CD18 Antigens / Q000276:immunology* / Q000378:metabolism; D055252:Cell-Derived Microparticles / Q000276:immunology* / Q000378:metabolism / Q000382:microbiology / Q000648:ultrastructure; D006801:Humans; D051379:Mice; D008807:Mice, Inbred BALB C; D046529:Microscopy, Electron, Transmission; D013290:Streptococcal Infections / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D013297:Streptococcus pyogenes / Q000276:immunology* / Q000378:metabolism / Q000648:ultrastructure
D039481:CD11b Antigen; D018821:CD18 Antigens; C509295:ITGAM protein, human